AU616674B2 - Compound, composition and method for the reduction of lipids the modification of the affinity of hemoglobin for oxygen and the prevention of platelet aggregation - Google Patents

Compound, composition and method for the reduction of lipids the modification of the affinity of hemoglobin for oxygen and the prevention of platelet aggregation

Info

Publication number
AU616674B2
AU616674B2 AU19986/88A AU1998688A AU616674B2 AU 616674 B2 AU616674 B2 AU 616674B2 AU 19986/88 A AU19986/88 A AU 19986/88A AU 1998688 A AU1998688 A AU 1998688A AU 616674 B2 AU616674 B2 AU 616674B2
Authority
AU
Australia
Prior art keywords
compound
carbon atoms
hemoglobin
phenoxy
straight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU19986/88A
Other languages
English (en)
Other versions
AU1998688A (en
Inventor
Iraj Lalezari
Parviz Lalezari
Samuel Rahbar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU1998688A publication Critical patent/AU1998688A/en
Application granted granted Critical
Publication of AU616674B2 publication Critical patent/AU616674B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C07C275/34—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU19986/88A 1987-06-15 1988-06-15 Compound, composition and method for the reduction of lipids the modification of the affinity of hemoglobin for oxygen and the prevention of platelet aggregation Ceased AU616674B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6223687A 1987-06-15 1987-06-15
US062236 1987-06-15

Publications (2)

Publication Number Publication Date
AU1998688A AU1998688A (en) 1989-01-19
AU616674B2 true AU616674B2 (en) 1991-11-07

Family

ID=22041101

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19986/88A Ceased AU616674B2 (en) 1987-06-15 1988-06-15 Compound, composition and method for the reduction of lipids the modification of the affinity of hemoglobin for oxygen and the prevention of platelet aggregation

Country Status (4)

Country Link
EP (1) EP0358724A4 (de)
JP (1) JPH02503797A (de)
AU (1) AU616674B2 (de)
WO (1) WO1988010113A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4921997A (en) * 1988-06-15 1990-05-01 Montefiore Medical Center Method of synthesis and novel compounds for pharmaceutical uses
US5049695A (en) * 1990-02-12 1991-09-17 Center For Innovative Technology Allosteric hemoglobin modifiers
US5382680A (en) * 1990-12-07 1995-01-17 The Center For Innovative Technology Allosteric hemoglobin modifier compounds
GB9027023D0 (en) * 1990-12-12 1991-01-30 Wellcome Found Anti-atherosclerotic aryl compounds
DK0641770T3 (da) * 1993-03-17 1998-06-02 Meiji Seika Co Hidtil ukendte forbindelser med blodpladeaggegationsinhiberende aktivitet

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2614045A1 (de) * 1976-04-01 1977-10-06 Boehringer Mannheim Gmbh Neue phenoxyalkylcarbonsaeuren und verfahren zur herstellung derselben

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2614045A1 (de) * 1976-04-01 1977-10-06 Boehringer Mannheim Gmbh Neue phenoxyalkylcarbonsaeuren und verfahren zur herstellung derselben

Also Published As

Publication number Publication date
JPH02503797A (ja) 1990-11-08
EP0358724A1 (de) 1990-03-21
EP0358724A4 (de) 1990-06-05
AU1998688A (en) 1989-01-19
WO1988010113A1 (en) 1988-12-29

Similar Documents

Publication Publication Date Title
KR0159095B1 (ko) 벤조일구아니딘, 이의 제조방법 및 이를 함유하는 약제학적 조성물
US3261859A (en) Basically substituted phenyl acetonitrile compounds
JP3231042B2 (ja) ２−（２，６−ジ−ハロ−フェニルアミノ）フェニル酢酸の誘導体の硝酸エステルおよびその製造法
US5268500A (en) Compound, composition and method for the reduction of lipids the modification of the affinity of hemoblogin for oxygen and the prevention of platelet aggregation
US4921997A (en) Method of synthesis and novel compounds for pharmaceutical uses
JPH069545A (ja) ｏ−置換ベンゾイルグアニジン、その製造方法、医薬または診断剤としてのその使用およびそれを含有する医薬
JP3499905B2 (ja) グアニジンアルキル−１，１−ビスホスホン酸誘導体、その製法およびその使用
IE64603B1 (en) Antihyperlipidemic and antiatherosclerotic urea compounds
US4743611A (en) Naphthalenylsulfonylimidazolidinediones and their thioxo analogs useful as aldose reductase inhibitors
JPH06256290A (ja) ３，５−置換されたアミノベンゾイルグアニジン、それらの製法、医薬または診断剤としてのそれらの使用およびそれらを含有する医薬
AU616674B2 (en) Compound, composition and method for the reduction of lipids the modification of the affinity of hemoglobin for oxygen and the prevention of platelet aggregation
US5472981A (en) Method of synthesis and novel compounds for pharmaceutical uses
US4925968A (en) N-acyl-N-naphthoylglycines as aldose reductase inhibitors
SK319892A3 (en) N-phenyl-2-cyano-3-hydroxycrotonamide derivatives, method of their poduction and their using for manufacture of medicines with immunomodulating effect
DE68912843T2 (de) Parabansäure-Derivate und pharmazeutische Zusammensetzungen damit.
JPS5925794B2 (ja) 尿素のヘテロシクリルカルボニル誘導体
PT86677B (pt) Processo para a preparacao de cinolina-carboxamidas e de composicoes farmaceuticas que as contem
JP3003941B2 (ja) 新規なｎ―〔置換アリール〕―ｎ’―〔置換アルコキシ〕―尿素およびチォ尿素誘導体
US4233310A (en) Antiarteriosclerotic N-(mercaptoacyl)-histidines
AU777602B2 (en) An improving agent for hypoalbuminaemia
JPS61286359A (ja) Ｎ−〔〔５−（トリフルオロメチル）−６−メトキシ−１−ナフタレニル〕チオキソメチルまたはカルボニル〕−ｎ−メチルグリシンアミド
US5116857A (en) Method of increasing gastrointestinal motility with substituted benzamides
US4514390A (en) Melaminylthioarsenites
US4923896A (en) N-(substituted aryl)-N'-(substituted alkoxy)-ureas and thioureas as antihypercholesterolemic and antiatherosclerotic agents
US5475028A (en) 2-aminoethanesulfonic acid zinc complex